• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受 LLV 治疗的 HIV 感染者 CD4 T 细胞的转录组分析揭示了新型转录因子调节 HIV-1 启动子活性。

Transcriptome analysis of CD4 T cells from HIV-infected individuals receiving ART with LLV revealed novel transcription factors regulating HIV-1 promoter activity.

机构信息

Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510060, China.

Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China; Guangzhou Laboratory, Bio-Island, Guangzhou, 510320, China.

出版信息

Virol Sin. 2023 Jun;38(3):398-408. doi: 10.1016/j.virs.2023.03.001. Epub 2023 Mar 11.

DOI:10.1016/j.virs.2023.03.001
PMID:36907331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10311176/
Abstract

Some HIV-infected individuals receiving ART develop low-level viremia (LLV), with a plasma viral load of 50-1000 copies/mL. Persistent low-level viremia is associated with subsequent virologic failure. The peripheral blood CD4 T cell pool is a source of LLV. However, the intrinsic characteristics of CD4 T cells in LLV which may contribute to low-level viremia are largely unknown. We analyzed the transcriptome profiling of peripheral blood CD4 T cells from healthy controls (HC) and HIV-infected patients receiving ART with either virologic suppression (VS) or LLV. To identify pathways potentially responding to increasing viral loads from HC to VS and to LLV, KEGG pathways of differentially expressed genes (DEGs) were acquired by comparing VS with HC (VS-HC group) and LLV with VS (LLV-VS group), and overlapped pathways were analyzed. Characterization of DEGs in key overlapping pathways showed that CD4 T cells in LLV expressed higher levels of Th1 signature transcription factors (TBX21), toll-like receptors (TLR-4, -6, -7 and -8), anti-HIV entry chemokines (CCL3 and CCL4), and anti-IL-1β factors (ILRN and IL1R2) compared to VS. Our results also indicated activation of the NF-κB and TNF signaling pathways that could promote HIV-1 transcription. Finally, we evaluated the effects of 4 and 17 transcription factors that were upregulated in the VS-HC and LLV-VS groups, respectively, on HIV-1 promoter activity. Functional studies revealed that CXXC5 significantly increased, while SOX5 markedly suppressed HIV-1 transcription. In summary, we found that CD4 T cells in LLV displayed a distinct mRNA profiling compared to that in VS, which promoted HIV-1 replication and reactivation of viral latency and may eventually contribute to virologic failure in patients with persistent LLV. CXXC5 and SOX5 may serve as targets for the development of latency-reversing agents.

摘要

一些接受抗逆转录病毒治疗(ART)的 HIV 感染者会出现低水平病毒血症(LLV),其血浆病毒载量为 50-1000 拷贝/ml。持续性低水平病毒血症与随后的病毒学失败相关。外周血 CD4 T 细胞池是 LLV 的来源。然而,导致 LLV 的 CD4 T 细胞的内在特征在很大程度上尚不清楚。我们分析了来自健康对照者(HC)和接受 ART 治疗且病毒学抑制(VS)或 LLV 的 HIV 感染者的外周血 CD4 T 细胞的转录组谱。为了鉴定从 HC 到 VS 和 LLV 时可能对病毒载量增加做出反应的途径,我们通过比较 VS 与 HC(VS-HC 组)和 LLV 与 VS(LLV-VS 组)来获得差异表达基因(DEG)的 KEGG 途径,并分析重叠途径。关键重叠途径中 DEG 的特征表明,与 VS 相比,LLV 中的 CD4 T 细胞表达更高水平的 Th1 特征转录因子(TBX21)、Toll 样受体(TLR-4、-6、-7 和-8)、抗 HIV 进入趋化因子(CCL3 和 CCL4)和抗 IL-1β 因子(ILRN 和 IL1R2)。我们的结果还表明,NF-κB 和 TNF 信号通路的激活可能会促进 HIV-1 转录。最后,我们评估了分别在 VS-HC 和 LLV-VS 组中上调的 4 种和 17 种转录因子对 HIV-1 启动子活性的影响。功能研究表明,CXXC5 显著增加,而 SOX5 则明显抑制 HIV-1 转录。总之,我们发现与 VS 相比,LLV 中的 CD4 T 细胞表现出明显不同的 mRNA 谱,从而促进 HIV-1 复制和病毒潜伏的重新激活,最终可能导致持续性 LLV 患者的病毒学失败。CXXC5 和 SOX5 可作为开发潜伏逆转剂的靶标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/afee600417e5/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/8c670c055341/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/1bea06d5372f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/e39036bf6058/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/76de2c0ba8a1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/b0da4a03a95a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/e3a766ba7694/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/afee600417e5/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/8c670c055341/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/1bea06d5372f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/e39036bf6058/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/76de2c0ba8a1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/b0da4a03a95a/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/e3a766ba7694/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5678/10311176/afee600417e5/figs1.jpg

相似文献

1
Transcriptome analysis of CD4 T cells from HIV-infected individuals receiving ART with LLV revealed novel transcription factors regulating HIV-1 promoter activity.接受 LLV 治疗的 HIV 感染者 CD4 T 细胞的转录组分析揭示了新型转录因子调节 HIV-1 启动子活性。
Virol Sin. 2023 Jun;38(3):398-408. doi: 10.1016/j.virs.2023.03.001. Epub 2023 Mar 11.
2
HIV-1 low-level viremia affects T cell activation rather than T cell development in school-age children, adolescents, and young adults during antiretroviral therapy.在抗逆转录病毒治疗期间,HIV-1 低水平病毒血症影响学龄儿童、青少年和年轻成人的 T 细胞激活,而不是 T 细胞发育。
Int J Infect Dis. 2020 Feb;91:210-217. doi: 10.1016/j.ijid.2019.12.001. Epub 2019 Dec 7.
3
Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.在一组 HIV 阳性患者中,持续低水平病毒血症后的病毒学失败:12 年观察结果。
Clin Infect Dis. 2013 Nov;57(10):1489-96. doi: 10.1093/cid/cit529. Epub 2013 Aug 14.
4
Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy.接受抗逆转录病毒治疗的 HIV 感染者的低水平病毒血症和病毒学失败。
AIDS. 2019 Nov 1;33(13):2005-2012. doi: 10.1097/QAD.0000000000002306.
5
Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort.与导致病毒学失败的高风险低水平病毒血症相关的因素:对中国抗逆转录病毒治疗队列的 16 年回顾性研究。
BMC Infect Dis. 2020 Feb 17;20(1):147. doi: 10.1186/s12879-020-4837-y.
6
All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study.在接受联合抗逆转录病毒治疗期间,人类免疫缺陷病毒低病毒血症成人的全因死亡率和严重非艾滋病事件:来自瑞典全国观察性研究的结果。
Clin Infect Dis. 2021 Jun 15;72(12):2079-2086. doi: 10.1093/cid/ciaa413.
7
Factors associated with human immunodeficiency virus-1 low-level viremia and its impact on virological and immunological outcomes: A retrospective cohort study in Beijing, China.与人类免疫缺陷病毒-1 低水平病毒血症相关的因素及其对病毒学和免疫学结果的影响:中国北京的一项回顾性队列研究。
HIV Med. 2022 Mar;23 Suppl 1:72-83. doi: 10.1111/hiv.13251.
8
HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.博茨瓦纳在接受联合抗逆转录病毒治疗(ART)时低病毒血症个体中的 HIV-1 耐药突变。
J Antimicrob Chemother. 2022 Apr 27;77(5):1385-1395. doi: 10.1093/jac/dkac056.
9
Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy: A Swedish observational study.与开始抗逆转录病毒治疗的 HIV 感染者低病毒血症相关的因素:一项瑞典观察性研究。
PLoS One. 2022 May 17;17(5):e0268540. doi: 10.1371/journal.pone.0268540. eCollection 2022.
10
Low-Level Viremia Predicts Virological Failure in HIV-Infected Omani Patients Receiving Antiretroviral Therapy.低水平病毒血症可预测接受抗逆转录病毒治疗的阿曼 HIV 感染患者的病毒学失败。
J Int Assoc Provid AIDS Care. 2020 Jan-Dec;19:2325958220979817. doi: 10.1177/2325958220979817.

引用本文的文献

1
Multi-omics single-cell analysis reveals key regulators of HIV-1 persistence and aberrant host immune responses in early infection.多组学单细胞分析揭示了HIV-1早期感染持续存在和宿主异常免疫反应的关键调节因子。
Elife. 2025 Aug 21;14:RP104856. doi: 10.7554/eLife.104856.
2
Transposable elements may enhance antiviral resistance in HIV-1 elite controllers.转座元件可能增强HIV-1精英控制者的抗病毒抗性。
Genome Biol. 2025 Feb 24;26(1):28. doi: 10.1186/s13059-025-03484-y.
3
Signal integrator function of CXXC5 in Cancer.CXXC5在癌症中的信号整合功能。

本文引用的文献

1
β-catenin regulates HIV latency and modulates HIV reactivation.β-连环蛋白调节 HIV 潜伏期并调节 HIV 再激活。
PLoS Pathog. 2022 Mar 7;18(3):e1010354. doi: 10.1371/journal.ppat.1010354. eCollection 2022 Mar.
2
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry.低 CCR5 表达可保护精英控制者的 HIV 特异性 CD4+T 细胞免受病毒进入。
Nat Commun. 2022 Jan 26;13(1):521. doi: 10.1038/s41467-022-28130-0.
3
Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status.
Cell Commun Signal. 2025 Jan 14;23(1):25. doi: 10.1186/s12964-024-02005-x.
4
Evaluation of the performance of a qPCR-based assay for HIV-1 viral load determination.基于定量聚合酶链反应(qPCR)的检测方法用于测定HIV-1病毒载量的性能评估。
PLoS One. 2024 Dec 13;19(12):e0315579. doi: 10.1371/journal.pone.0315579. eCollection 2024.
5
HIV-1 Vpr Functions in Primary CD4 T Cells.HIV-1 Vpr 在原代 CD4 T 细胞中的功能。
Viruses. 2024 Mar 9;16(3):420. doi: 10.3390/v16030420.
6
Transposable elements may enhance antiviral resistance in HIV-1 elite controllers.转座元件可能增强HIV-1精英控制者的抗病毒抗性。
bioRxiv. 2023 Dec 12:2023.12.11.571123. doi: 10.1101/2023.12.11.571123.
7
Drug Resistance Profile Among HIV-1 Infections Experiencing ART with Low-Level Viral Load in Guangdong China During 2011-2022: A Retrospective Study.2011 - 2022年中国广东低病毒载量接受抗逆转录病毒治疗的HIV-1感染患者的耐药情况:一项回顾性研究
Infect Drug Resist. 2023 Jul 31;16:4953-4964. doi: 10.2147/IDR.S419610. eCollection 2023.
HIV 治疗不足患者持续低水平病毒血症:未解决的现状。
Virulence. 2021 Dec;12(1):2919-2931. doi: 10.1080/21505594.2021.2004743.
4
[Chinese guidelines for diagnosis and treatment of HIV/AIDS (2021 edition)].《中国艾滋病诊疗指南(2021年版)》
Zhonghua Nei Ke Za Zhi. 2021 Dec 1;60(12):1106-1128. doi: 10.3760/cma.j.cn112138-20211006-00676.
5
IL-10 as a Th2 Cytokine: Differences Between Mice and Humans.IL-10 作为一种 Th2 细胞因子:小鼠和人类之间的差异。
J Immunol. 2021 Nov 1;207(9):2205-2215. doi: 10.4049/jimmunol.2100565.
6
Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy.高效抗逆转录病毒治疗的 HIV-1 感染成人中,残余病毒血症与特定的免疫激活特征相关联。
Front Immunol. 2021 Mar 30;12:663843. doi: 10.3389/fimmu.2021.663843. eCollection 2021.
7
Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis.在初治 HIV-1 感染者中,与常见核心药物相比,多替拉韦的疗效、安全性和持久性:系统评价和网络荟萃分析的更新。
BMC Infect Dis. 2021 Feb 26;21(1):222. doi: 10.1186/s12879-021-05850-0.
8
Interleukin-1 as Innate Mediator of T Cell Immunity.白细胞介素-1 作为 T 细胞免疫的先天介质。
Front Immunol. 2021 Jan 27;11:621931. doi: 10.3389/fimmu.2020.621931. eCollection 2020.
9
Interactions with Commensal and Pathogenic Bacteria Induce HIV-1 Latency in Macrophages through Altered Transcription Factor Recruitment to the LTR.与共生菌和致病菌的相互作用通过改变转录因子与长末端重复序列(LTR)的结合诱导巨噬细胞中的HIV-1潜伏。
J Virol. 2021 Mar 10;95(7). doi: 10.1128/JVI.02141-20. Epub 2021 Jan 20.
10
Update on Adverse Effects of HIV Integrase Inhibitors.HIV整合酶抑制剂不良反应的最新情况
Curr Treat Options Infect Dis. 2019;11(4):372-387. doi: 10.1007/s40506-019-00203-7. Epub 2019 Nov 16.